<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochem Biophys Res Commun</journal-id>
      <journal-title>Biochemical and Biophysical Research Communications</journal-title>
      <issn pub-type="ppub">0006-291X</issn>
      <issn pub-type="epub">1090-2104</issn>
      <publisher>
        <publisher-name>Academic Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">1899526</article-id>
      <article-id pub-id-type="pmid">17560943</article-id>
      <article-id pub-id-type="publisher-id">YBBRC18954</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbrc.2007.05.177</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>An outwardly rectifying anionic background current in atrial myocytes from the human heart</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>H.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hancox</surname>
            <given-names>J.C.</given-names>
          </name>
          <email>jules.hancox@bristol.ac.uk</email>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kozlowski</surname>
            <given-names>R.Z.</given-names>
          </name>
          <email>roland.kozlowski@lectusth.com</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line><sup>a</sup>Department of Pharmacology, Bristol Heart Institute, School of Medical Sciences, The University of Bristol, University Walk, Bristol BS8 1TD, UK</addr-line>
      </aff>
      <aff id="aff2">
        <addr-line><sup>b</sup>Department of Physiology, Bristol Heart Institute, School of Medical Sciences, The University of Bristol, University Walk, Bristol BS8 1TD, UK</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line><sup>c</sup>Biological Physics Group, School of Physics &amp; Astronomy, The University of Manchester, Manchester M60 1QD, UK</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding authors. <email>jules.hancox@bristol.ac.uk</email><email>roland.kozlowski@lectusth.com</email></corresp>
        <fn id="fn1">
          <label>1</label>
          <p>Present address: Lectus Therapeutics Limited, Babraham Research Campus, Cambridge CB223AT, UK.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>03</day>
        <month>8</month>
        <year>2007</year>
      </pub-date>
      <volume>359</volume>
      <issue>3</issue>
      <fpage>765</fpage>
      <lpage>770</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>5</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2007 Elsevier Inc.</copyright-statement>
        <copyright-year>2007</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>This report describes a hitherto unreported anionic background current from human atrial cardiomyocytes. Under whole-cell patch-clamp with anion-selective conditions, an outwardly rectifying anion current (<italic>I</italic><sub>ANION</sub>) was observed, which was larger with iodide than nitrate, and with nitrate than chloride as charge carrier. In contrast with a previously identified background anionic current from small mammal cardiomyocytes, <italic>I</italic><sub>ANION</sub> was not augmented by the pyrethroid tefluthrin (10 μM); neither was it inhibited by hyperosmolar external solution nor by DIDS (200 μM); thus <italic>I</italic><sub>ANION</sub> was not due to basal activity of volume-sensitive anion channels. <italic>I</italic><sub>ANION</sub> was partially inhibited by the Cl<sup>−</sup> channel blockers NPPB (50 μM) and Gly H-101 (30 μM). Incorporation of <italic>I</italic><sub>ANION</sub> into a human atrial action potential (AP) simulation led to depression of the AP plateau, accompanied by alterations to plateau inward calcium current, and to AP shortening at 50% but not 90% of complete repolarization, demonstrating that <italic>I</italic><sub>ANION</sub> can influence the human atrial AP profile.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Action potential</kwd>
        <kwd>Anion</kwd>
        <kwd>Anionic</kwd>
        <kwd>Atrium</kwd>
        <kwd>Atrial myocyte</kwd>
        <kwd>Background current</kwd>
        <kwd>Cardiac</kwd>
        <kwd>Computer modelling</kwd>
        <kwd>Heart</kwd>
        <kwd>Patch-clamp</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>The electrophysiological behaviour of cardiac myocytes from mammalian hearts is determined by the combined activity of a range of different cation and anion channel types. The reversal potential for chloride (Cl<sup>−</sup>) ions in the heart (<italic>E</italic><sub>Cl</sub>) lies between ∼−60 and −40 mV <xref rid="bib1" ref-type="bibr">[1]</xref>. Negative to <italic>E</italic><sub>Cl</sub> outward Cl<sup>−</sup> movement generates depolarizing ionic current, whilst positive to <italic>E</italic><sub>Cl</sub> inward Cl<sup>−</sup> movement generates repolarizing ionic current. Therefore, the activation of Cl<sup>−</sup> channels can influence both the resting membrane potential and the duration of cardiac action potentials (APs) (<xref rid="bib1 bib2 bib3" ref-type="bibr">[1–3]</xref> for reviews). Several different anion channel types have been identified that may contribute to cardiac physiology and pathophysiology <xref rid="bib1 bib2 bib3" ref-type="bibr">[1–3]</xref>. Of the cardiac anion channel currents thus far identified, the three major types are: (i) a cystic fibrosis transmembrane conductance regulator (CFTR) current-activated through cAMP-dependent phosphorylation (<italic>I</italic><sub>Cl,cAMP</sub>; e.g. <xref rid="bib4 bib5 bib6" ref-type="bibr">[4–6]</xref>); (ii) a stretch- or swelling-activated Cl<sup>−</sup> current (<italic>I</italic><sub>Cl,Swell</sub>; e.g. <xref rid="bib7 bib8 bib9" ref-type="bibr">[7–9]</xref>) and (iii) a Ca<sup>2+</sup>-activated Cl<sup>−</sup> current (<italic>I</italic><sub>Cl,Ca</sub>; e.g. <xref rid="bib10 bib11 bib12" ref-type="bibr">[10–12]</xref>).</p>
    <p>Recently, an outwardly rectifying anionic background current (<italic>I</italic><sub>AB</sub>) has been identified in cardiac myocytes from two commonly studied model species (rat and guinea-pig) using whole-cell patch-clamp measurements <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref>. <italic>I</italic><sub>AB</sub> is distinct from previously identified Cl<sup>−</sup> currents as it has a distinct permeability sequence <mml:math id="M1" altimg="si13.gif" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts><mml:mo>&gt;</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">I</mml:mi></mml:mrow><mml:mrow><mml:mi>−</mml:mi></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math> and is insensitive to the stilbene diphosphonate Cl<sup>−</sup> channel inhibitor DIDS, to cell swelling and to intracellular Ca<sup>2+</sup> and cAMP <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref>. <italic>I</italic><sub>AB</sub> can also be differentiated from other major cardiac anion currents as it can be activated by the pyrethroid agent tefluthrin <xref rid="bib14" ref-type="bibr">[14]</xref>. Anion substitution experiments have provided evidence that <italic>I</italic><sub>AB</sub> can influence AP duration (APD) <xref rid="bib13" ref-type="bibr">[13]</xref>. There is some disagreement as to whether or not a basally active anionic current exists in human atrium <xref rid="bib15 bib16" ref-type="bibr">[15,16]</xref> and there is no information as to whether humans exhibit an <italic>I</italic><sub>AB</sub> with the characteristics of that seen in small mammal hearts. Therefore, the present study was undertaken to determine whether or not <italic>I</italic><sub>AB</sub> exists in adult human cardiac myocytes. The resulting findings indicate the presence in human atrial myocytes of an outwardly rectifying anionic background current (<italic>I</italic><sub>ANION</sub>). Notably, the <italic>I</italic><sub>ANION</sub> observed in this study has the potential to contribute to human atrial electrophysiology, but is distinct from both the <italic>I</italic><sub>AB</sub> recorded previously from myocytes from small mammal hearts <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref> and from outwardly rectifying stilbene diphosphonate-sensitive anionic currents recorded previously from human atrium <xref rid="bib17" ref-type="bibr">[17]</xref>.</p>
    <sec sec-type="materials-methods">
      <title>Methods</title>
      <sec>
        <title>Atrial myocyte isolation</title>
        <p>The study was approved by the local Central and South Bristol Research Ethics Committee and was conducted in accordance with the principles of the Declaration of Helsinki. Human right atrial appendages were obtained, with consent, from 32 patients (27 males, 5 females, average age 69.7 ± 1.7 years) undergoing coronary artery bypass surgery. Single human atrial myocytes were isolated from right atrial appendages by mechanical and enzymatic dispersion. Tissue samples were quickly immersed in cardioplegic solution (see <xref rid="tbl1" ref-type="table">Table 1</xref>; solution G, 100% O<sub>2</sub>, ice cold). The samples were chopped into small chunks and washed with an EGTA-containing solution (see <xref rid="tbl1" ref-type="table">Table 1</xref>; solution H) gassed with 100% O<sub>2</sub> for 15 min at 37 °C. The chunks were then incubated in the same solution from which EGTA was excluded and protease type XXIV (3 U/ml, Sigma) and collagenase type V (250 U/ml, Sigma) were added. The medium was continuously gassed with 100% O<sub>2</sub> at 37 °C. After 15 min, the incubation medium was substituted for the same solution containing collagenase only. Myocytes were progressively released from the chunks into the supernatant and their yield monitored under a microscope. The suspension was washed in enzyme-free solution and the myocytes were stored at room temperature until use (within ∼8 h of cell isolation).</p>
      </sec>
      <sec>
        <title>Electrophysiology</title>
        <p><italic>Solutions used.</italic> Experimental solutions for the investigation of anionic current were similar to those used previously to study <italic>I</italic><sub>AB</sub> <xref rid="bib14" ref-type="bibr">[14]</xref>; the composition of all solutions used is given in <xref rid="tbl1" ref-type="table">Table 1</xref>. Osmolarity values given for each of the solutions listed in <xref rid="tbl1" ref-type="table">Table 1</xref> were measured using a micro-osmometer employing a freezing-point method (Advanced Instruments, Norwood, MA, USA). Myocytes used in whole-cell voltage-clamp experiments were superfused (20–25 °C) with a standard Hepes-buffered Tyrode’s solution (see <xref rid="tbl1" ref-type="table">Table 1</xref>; solution A) until the whole-cell recording configuration had been obtained. For isolation of background anion current, sodium-free Tyrode’s solutions were used (solutions B–E) in which Na was replaced by <italic>N</italic>-methyl-<sc>d</sc>-glucamine (NMDG), with one of several possible dominant anions: solution B, chloride; solution C, aspartate; solution D, iodide; solution E, nitrate. All drugs used were added to solution E from stock solutions made in dimethyl sulfoxide (DMSO) with an exception of <italic>N</italic>-(2-naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide (Gly H-101), which was solved in distilled water. The hyperosmotic external solution (solution F) was prepared by adding 70 mM sucrose to solution E. A Cs-based pipette solution (solution I) was used for all experiments. Solution I was sodium-free to prevent contamination of chloride currents by the sodium–calcium exchanger current.</p>
        <p><italic>Drugs.</italic> Diisothiocyanostilbene-2,2′-disulfonic acid (DIDS, final concentration 200 μM), 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB, final concentration 50 μM) and tefluthrin (TEF, final concentration 10 μM) were purchased from Sigma Chemical Co. (Poole, UK). <italic>N</italic>-(2-naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide (Gly H-101, final concentrations of 10 and 30 μM) was purchased from Merck (Frankfurt, Germany). All the drug-containing solutions were protected from light throughout.</p>
      </sec>
      <sec>
        <title>Electrophysiological recording</title>
        <p>In electrophysiological experiments, junction potential changes were minimized by immersing the reference Ag/AgCl electrode in a 3 M KCl solution with a continuous agar bridge (4% agar in 3 M KCl). Borosilicate glass pipettes (Harvard Apparatus, UK) were pulled using a vertical two-step Narishige PP-830 microelectrode puller (Narishige, Japan) and had a tip resistance of 5–7 MΩ when filled with the pipette solution. During anion substitution experiments, background anion current was elicited from voltage-clamped myocytes (superfused with solutions B, C, D and E in the whole-cell configuration) by depolarizing ramps from −90 to +70 mV from a holding potential of −50 mV (ramp rate of 0.32 V s<sup>−1</sup>; sweep duration 1.03 s). A holding potential of −50 mV was used to inactivate the Na<sup>+</sup>-current and T-type Ca<sup>2+</sup>-current.</p>
        <p>Recordings were made using an Axopatch 200A amplifier, and data were recorded on computer using pClamp v. 9.0 software (Axon Instruments, Forster City, CA). Data were analyzed using the Clampfit program of pClamp v. 9.0.</p>
        <p>Mean values of averaged original signals over five command pulses were used for statistical analysis. Hyperpolarizing voltage steps of −20 mV and 5 ms duration were applied at 20 Hz to record the capacitance transients required for direct integration and the calculation of cell capacitance. The statistical significance between control and the drug periods or <mml:math id="M2" altimg="si14.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and other anions were determined by the Paired Student’s <italic>t</italic>-test using either Microsoft Excel or GraphPad Prism v. 4.0. The statistical significance between the normal and hyperosmotic <mml:math id="M3" altimg="si15.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> solutions was calculated with two-way ANOVA test using GraphPad Prism v. 4.0. Statistical significance was considered to refer to the 95% level of confidence (<italic>p</italic> &lt; 0.05).</p>
      </sec>
      <sec>
        <title>Human atrial action potential simulations</title>
        <p>The Courtemanche et al. human atrial action potential (AP) model <xref rid="bib18" ref-type="bibr">[18]</xref> was modified to incorporate a formulation for <italic>I</italic><sub>ANION</sub> based on the experimental data obtained with <mml:math id="M4" altimg="si16.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and Cl<sup>−</sup> in <xref rid="fig1 fig2" ref-type="fig">Figs. 1 and 2</xref>. Readers are referred to <xref rid="bib18" ref-type="bibr">[18]</xref> for the general equations required to set up the model. The following equation was used to simulate anionic background current (<italic>I</italic><sub>ANION</sub>)<disp-formula id="fd1"><label>(1)</label><mml:math id="M5" altimg="si17.gif" overflow="scroll"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mtext>ANION</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mtext>ANION</mml:mtext></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mtext>ANION</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>d</mml:mi><mml:mo>×</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mtext>ANION</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula>where <italic>E</italic><sub>ANION</sub> represents the current reversal potential and <italic>g</italic><sub>ANION</sub> is the conductance of <italic>I</italic><sub>ANION</sub>. By fitting Eq. <xref rid="fd1" ref-type="disp-formula">(1)</xref> to experimental data shown in <xref rid="fig1" ref-type="fig">Fig. 1</xref>B and scaled to the mean data shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>A, we obtained <italic>g</italic><sub>ANION</sub> = 0.37 pS/pF, <italic>E</italic><sub>ANION</sub> = −45.64 mV, <italic>c</italic> = 0.87, <italic>d</italic> = 8.4 × 10<sup>−4</sup> mV<sup>−1</sup> for the <mml:math id="M6" altimg="si18.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>-sensitive <italic>I</italic><sub>ANION</sub>, and <italic>g</italic><sub>ANION</sub> = 0.19 pS/pF, <italic>c</italic> = 0.94, <italic>d</italic> = 2.5 × 10<sup>−4</sup> mV<sup>−1</sup> for the Cl<sup>−</sup>-sensitive <italic>I</italic><sub>ANION</sub>.</p>
      </sec>
    </sec>
    <sec>
      <title>Results and discussion</title>
      <p>The voltage protocol used for these experiments was similar to that used previously to study <italic>I</italic><sub>AB</sub> present in cardiomyocytes from small mammal hearts <xref rid="bib14" ref-type="bibr">[14]</xref> and is shown as an inset to <xref rid="fig1" ref-type="fig">Fig. 1</xref>A. From a holding potential of −50 mV, ascending voltage ramps were applied between −90 and +70 mV. This protocol was applied to cells superfused first with aspartate (Asp)-containing solution (solution C) and then with different superfusates containing more permeant anions. <xref rid="fig1" ref-type="fig">Fig. 1</xref>A shows an example of the net current traces obtained from a cell superfused serially with solutions containing Asp<sup>−</sup>, Cl<sup>−</sup>, <mml:math id="M7" altimg="si19.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and I<sup>−</sup>. Both inward and, particularly, outward current components were greater with Cl<sup>−</sup>, <mml:math id="M8" altimg="si20.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and I<sup>−</sup> than with Asp<sup>−</sup> in the external superfusate. <xref rid="fig1" ref-type="fig">Fig. 1</xref>B shows current traces for the same cell, obtained by subtracting the current in Asp<sup>−</sup> from that with each of the more permeant anions. With each of Cl<sup>−</sup>, <mml:math id="M9" altimg="si21.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and I<sup>−</sup>, the Asp<sup>−</sup>-sensitive difference current showed marked outward rectification. <xref rid="fig1" ref-type="fig">Fig. 1</xref>C compares the mean outward current amplitude at +60 mV (normalized to membrane capacitance) for the three anions. Compared to <mml:math id="M10" altimg="si22.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>, the observed current was significantly greater with I<sup>−</sup> and smaller with Cl<sup>−</sup> as charge carrier. These observations support the presence in human atrial cells of a basally active, anionic current (<italic>I</italic><sub>ANION</sub>); however, the relative current amplitudes with the three permeant anions differ from those observed previously with for the <italic>I</italic><sub>AB</sub> observed in myocytes from guinea-pig and rat hearts, where <italic>I</italic><sub>AB</sub> was largest with <mml:math id="M11" altimg="si23.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> (permeability sequence <mml:math id="M12" altimg="si24.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts><mml:mo>&gt;</mml:mo><mml:msup><mml:mrow><mml:mtext>I</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:msup><mml:mrow><mml:mtext>Cl</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math>; <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref>).</p>
      <p><xref rid="fig2" ref-type="fig">Fig. 2</xref>A shows the mean <italic>I</italic><sub>ANION</sub>–voltage relation for 19 atrial cells, with <mml:math id="M13" altimg="si25.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> as the major external anion (with <italic>I</italic><sub>ANION</sub> measured as the <mml:math id="M14" altimg="si26.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> − Asp<sup>−</sup> difference current). The mean current–voltage relation for the resulting current showed clear outward rectification, with an observed reversal potential (<italic>E</italic><sub>rev</sub>) for <italic>I</italic><sub>ANION</sub> in these experiments of −45.7 ± 2.2 mV (obtained by pooling <italic>E</italic><sub>rev</sub> values from individual experiments). Previous studies provide evidence that human atrial cells exhibit <italic>I</italic><sub>Cl, Swell</sub> (e.g. <xref rid="bib15 bib17 bib19 bib20 bib21" ref-type="bibr">[15,17,19–21]</xref>). Therefore, in order to determine whether or not <italic>I</italic><sub>ANION</sub> could be attributed to basal activity of channels mediating <italic>I</italic><sub>Cl,Swell</sub>, Asp<sup>−</sup> to <mml:math id="M15" altimg="si27.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> substitutions were also made using hyperosmolar external solution <xref rid="bib14" ref-type="bibr">[14]</xref>. The mean data from eight such experiments are shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>B. There was no statistically significant difference between the plotted densities of <italic>I</italic><sub>ANION</sub> from the <italic>I</italic>–<italic>V</italic> relation obtained in hyperosmolar solution and that shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>A, suggesting that <italic>I</italic><sub>ANION</sub> is distinct from <italic>I</italic><sub>Cl,Swell</sub>.</p>
      <p>In order to characterize further <italic>I</italic><sub>ANION</sub> from human atrial myocytes, the sensitivity of the current to a range of pharmacological interventions was tested. <xref rid="fig2" ref-type="fig">Fig. 2</xref>C summarises the effects of the various interventions (expressed as % changes in <mml:math id="M16" altimg="si28.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>-sensitive current at +60 mV). The stilbene disulphonate DIDS failed to inhibit <italic>I</italic><sub>ANION</sub> at a concentration (200 μM) that would be anticipated to inhibit <italic>I</italic><sub>Cl,Swell</sub> <xref rid="bib19 bib21" ref-type="bibr">[19,21]</xref>. On the other hand, tefluthrin (10 μM), which we have previously reported to activate the <italic>I</italic><sub>AB</sub> seen in myocytes from guinea-pig hearts <xref rid="bib14" ref-type="bibr">[14]</xref>, failed to alter significantly the amplitude of <italic>I</italic><sub>ANION</sub> from human atrial myocytes. Together with the relative <italic>I</italic><sub>ANION</sub> amplitudes in I<sup>−</sup>, Cl<sup>−</sup> and <mml:math id="M17" altimg="si29.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>, the lack of effect of tefluthrin indicates that <italic>I</italic><sub>ANION</sub> is distinct from the previously reported rat/guinea-pig <italic>I</italic><sub>AB</sub> <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref>. Moreover, the lack of significant inhibition of the current by DIDS or hyperosmolar solution makes the <italic>I</italic><sub>ANION</sub> observed in the present study distinct from <italic>I</italic><sub>Cl,Swell</sub> <xref rid="bib1" ref-type="bibr">[1]</xref> and from an osmolarity- and stilbene-sensitive outwardly rectifying chloride current recently reported by Demion and colleagues <xref rid="bib17" ref-type="bibr">[17]</xref>. NPPB (50 μM) produced a partial, statistically significant (<italic>p</italic> &lt; 0.05) inhibition of <italic>I</italic><sub>ANION</sub>. The glycine hydrazide Cl<sup>−</sup> channel inhibitor Gly H-101 failed to produce a significant blockade of <italic>I</italic><sub>ANION</sub> at 10 μM (∼7-fold greater than the reported IC<sub>50</sub> for CFTR channel inhibition at +60 mV <xref rid="bib22" ref-type="bibr">[22]</xref>); but produced partial attenuation of the current at 30 μM (∼20-fold the reported IC<sub>50</sub> for CFTR <xref rid="bib22" ref-type="bibr">[22]</xref>). Evidence for the presence of CFTR (<italic>I</italic><sub>Ca,cAMP</sub>) in human atrial cells is mixed <xref rid="bib1 bib15 bib19 bib20 bib21 bib23" ref-type="bibr">[1,15,19–21,23]</xref>, with a number of studies failing to observe the current in response to β-adrenergic stimulation, forskolin or cAMP (e.g. <xref rid="bib15 bib19 bib20 bib21" ref-type="bibr">[15,19–21]</xref>). Previous work has failed to find evidence for <italic>I</italic><sub>Cl,Ca</sub> in human atrial myocytes <xref rid="bib24" ref-type="bibr">[24]</xref> and, moreover, the presence of EGTA in the pipette dialysate (<xref rid="tbl1" ref-type="table">Table 1</xref>, solution I) and external [Ca<sup>2+</sup>] replacement in our experiments would have inhibited any [Ca<sup>2+</sup>]<sub>i</sub>-activated conductances on membrane depolarization. Therefore, the <italic>I</italic><sub>ANION</sub> seen here appears to differ not only from guinea-pig and rat <italic>I</italic><sub>AB</sub> <xref rid="bib13 bib14" ref-type="bibr">[13,14]</xref> but also from the three major reported cardiac anion conductances in: (i) being basally active and (ii) its overall pharmacological profile and sensitivity to anion substitution.</p>
      <p>In order to gain insight into the physiological role of <italic>I</italic><sub>ANION</sub>, the current was incorporated into human atrial AP simulations as outlined in the ‘Methods’. <xref rid="fig3" ref-type="fig">Fig. 3</xref>A shows the simulated APs (at an AP frequency of 1 Hz) from the Courtemanche et al. model <xref rid="bib18" ref-type="bibr">[18]</xref> both without (Control) and with inclusion of <italic>I</italic><sub>ANION</sub>, whilst <xref rid="fig3" ref-type="fig">Fig. 3</xref>B shows the corresponding current profiles during the time-course of the AP. With either <mml:math id="M18" altimg="si30.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and Cl<sup>−</sup> as charge carrier, incorporation of <italic>I</italic><sub>ANION</sub> into the model produced shortening of AP duration at 50% repolarization (APD<sub>50</sub>; the measured APD<sub>50</sub> values were 184, 165 and 159 ms for Control, Cl-sensitive <italic>I</italic><sub>ANION</sub> and NO<sub>3</sub>-sensitive <italic>I</italic><sub>ANION</sub>, respectively). In contrast, APD<sub>90</sub> was comparatively unaffected (the measured APD<sub>90</sub> was ∼305 ms under each condition) and resting potential also changed relatively little (with resting potential values of −81, −79 and −78 mV, respectively, for Control, <italic>I</italic><sub>ANION</sub> with Cl<sup>−</sup> and <italic>I</italic><sub>ANION</sub> with <mml:math id="M19" altimg="si31.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>). The more marked effect of <italic>I</italic><sub>ANION</sub> inclusion at less negative potentials during AP repolarization is concordant with the outwardly rectifying nature of the current. An additional observation made from the AP simulations is that incorporation of <italic>I</italic><sub>ANION</sub> also influenced the profile of L-type calcium current (<italic>I</italic><sub>Ca,L</sub>) during the AP plateau: the initial rapid component of <italic>I</italic><sub>Ca,L</sub> was unaffected by <italic>I</italic><sub>ANION</sub> incorporation, but the sustained component during the AP plateau showed a modest reduction. Thus, both an increase in repolarizing current carried by <italic>I</italic><sub>ANION</sub> and the consequent decrease in the sustained component of <italic>I</italic><sub>Ca,L</sub> combined to lead to AP plateau depression and abbreviation of APD<sub>50</sub>. The results shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref> demonstrate clearly that <italic>I</italic><sub>ANION</sub> is able to influence human atrial AP repolarization. Further work is now warranted to determine both the extent to which the incorporation/omission of <italic>I</italic><sub>ANION</sub> influences the susceptibility of human atrial cells and tissue to arrhythmia and to pursue the underlying identity and regulation of this novel background conductance.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This study was funded by British Heart Foundation project Grant PG/04/047. The authors thank Professor G. Angelini and Mr. A. Bryan for their assistance in the provision of atrial biopsy samples and Dr. A. James for advice on human atrial myocyte cell isolation.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>[1]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorota</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Insights into the structure, distribution and function of the cardiac chloride channels</article-title>
          <source>Cardiovasc. Res.</source>
          <year>1999</year>
          <volume>42</volume>
          <fpage>361</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="pmid">10533573</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>[2]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hume</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Collier</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Horowitz</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Anion transport in heart</article-title>
          <source>Physiol. Rev.</source>
          <year>2000</year>
          <volume>80</volume>
          <fpage>31</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">10617765</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>[3]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mulvaney</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Spencer</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Culliford</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Borg</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Kozlowski</surname>
              <given-names>R.Z.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac chloride channels: physiology, pharmacology and approaches for identifying novel modulators of activity</article-title>
          <source>Drug Discov. Today</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>492</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="pmid">11084386</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>[4]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harvey</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Hume</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>Autonomic regulation of a chloride current in heart</article-title>
          <source>Science</source>
          <year>1989</year>
          <volume>244</volume>
          <fpage>983</fpage>
          <lpage>985</lpage>
          <pub-id pub-id-type="pmid">2543073</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>[5]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bahinski</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nairn</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Greengard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Gadsby</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Chloride conductance regulated by cyclic AMP-dependent protein kinase in cardiac myocytes</article-title>
          <source>Nature</source>
          <year>1989</year>
          <volume>340</volume>
          <fpage>718</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="pmid">2475783</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <label>[6]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuoka</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ehara</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Noma</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Chloride-sensitive nature of the adrenaline-induced current in guinea-pig cardiac myocytes</article-title>
          <source>J. Physiol.</source>
          <year>1990</year>
          <volume>425</volume>
          <fpage>579</fpage>
          <lpage>598</lpage>
          <pub-id pub-id-type="pmid">1698979</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>[7]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorota</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Swelling-induced chloride-sensitive current in canine atrial cells revealed by whole-cell patch-clamp method</article-title>
          <source>Circ. Res.</source>
          <year>1992</year>
          <volume>70</volume>
          <fpage>679</fpage>
          <lpage>687</lpage>
          <pub-id pub-id-type="pmid">1551194</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>[8]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tseng</surname>
              <given-names>G.N.</given-names>
            </name>
          </person-group>
          <article-title>Cell swelling increases membrane conductance of canine cardiac cells: evidence for a volume-sensitive Cl− channel</article-title>
          <source>Am. J. Physiol.</source>
          <year>1992</year>
          <volume>262</volume>
          <fpage>C1056</fpage>
          <lpage>C1068</lpage>
          <pub-id pub-id-type="pmid">1314484</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>[9]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kirk</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Swelling-activated and isoprenaline-activated chloride currents in guinea pig cardiac myocytes have distinct electrophysiology and pharmacology</article-title>
          <source>J. Gen. Physiol.</source>
          <year>1994</year>
          <volume>104</volume>
          <fpage>997</fpage>
          <lpage>1017</lpage>
          <pub-id pub-id-type="pmid">7699368</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>[10]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawano</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hirayama</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hiraoka</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Activation mechanism of Ca2+-sensitive transient outward current in rabbit ventricular myocytes</article-title>
          <source>J. Physiol.</source>
          <year>1995</year>
          <volume>486</volume>
          <fpage>593</fpage>
          <lpage>604</lpage>
          <pub-id pub-id-type="pmid">7473222</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>[11]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sipido</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Callewaert</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Carmeliet</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>[Ca2+]i transients and [Ca2+]i-dependent chloride current in single Purkinje cells from rabbit heart</article-title>
          <source>J. Physiol.</source>
          <year>1993</year>
          <volume>468</volume>
          <fpage>641</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="pmid">8254529</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>[12]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zygmunt</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Gibbons</surname>
              <given-names>W.R.</given-names>
            </name>
          </person-group>
          <article-title>Properties of the calcium-activated chloride current in heart</article-title>
          <source>J. Gen. Physiol.</source>
          <year>1992</year>
          <volume>99</volume>
          <fpage>391</fpage>
          <lpage>414</lpage>
          <pub-id pub-id-type="pmid">1375275</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>[13]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spencer</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Kozlowski</surname>
              <given-names>R.Z.</given-names>
            </name>
          </person-group>
          <article-title>A novel anionic conductance affects action potential duration in isolated rat ventricular myocytes</article-title>
          <source>Br. J. Pharmacol.</source>
          <year>2000</year>
          <volume>129</volume>
          <fpage>235</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="pmid">10694227</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>[14]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borg</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Spencer</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Kozlowski</surname>
              <given-names>R.Z.</given-names>
            </name>
          </person-group>
          <article-title>Tefluthrin modulates a novel anionic background conductance (IAB) in guinea-pig ventricular myocytes</article-title>
          <source>Biochem. Biophys. Res. Comm.</source>
          <year>2002</year>
          <volume>292</volume>
          <fpage>208</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="pmid">11890694</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>[15]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Nattel</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Transmembrane chloride currents in human atrial myocytes</article-title>
          <source>Am. J. Physiol.</source>
          <year>1996</year>
          <volume>270</volume>
          <fpage>C500</fpage>
          <lpage>C507</lpage>
          <pub-id pub-id-type="pmid">8779912</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>[16]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berul</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Sweeten</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Vetter</surname>
              <given-names>V.L.</given-names>
            </name>
            <name>
              <surname>Morad</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Lack of cystic fibrosis transmembrane regulator-type chloride current in pediatric human atrial myocytes</article-title>
          <source>Life Sci.</source>
          <year>1997</year>
          <volume>60</volume>
          <fpage>189</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="pmid">9000643</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>[17]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demion</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Guinamard</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>El Chemaly</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rahmati</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bois</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>An outwardly rectifying chloride channel in human atrial cardiomyocytes</article-title>
          <source>J. Cardiovasc. Electrophysiol.</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>60</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">16426403</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>[18]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Courtemanche</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ramirez</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Nattel</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Ionic mechanisms underlying human atrial action potentials: insights from a mathematical model</article-title>
          <source>Am. J. Physiol.</source>
          <year>1998</year>
          <volume>275</volume>
          <fpage>H301</fpage>
          <lpage>H321</lpage>
          <pub-id pub-id-type="pmid">9688927</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>[19]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Koumi</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the stretch-activated chloride channel in isolated human atrial myocytes</article-title>
          <source>J. Membr. Biol.</source>
          <year>1998</year>
          <volume>163</volume>
          <fpage>67</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">9569251</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>[20]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hagiwara</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kasanuki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hosoda</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Chloride conductance in human atrial cells</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <year>1995</year>
          <volume>27</volume>
          <fpage>2403</fpage>
          <lpage>2408</lpage>
          <pub-id pub-id-type="pmid">8576955</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>[21]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oz</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Sorota</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Forskolin stimulates swelling-induced chloride current, not cardiac cystic fibrosis transmembrane-conductance regulator current, in human cardiac myocytes</article-title>
          <source>Circ. Res.</source>
          <year>1995</year>
          <volume>76</volume>
          <fpage>1063</fpage>
          <lpage>1070</lpage>
          <pub-id pub-id-type="pmid">7538915</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>[22]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muanprasat</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sonawane</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Salinas</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Taddei</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Galietta</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Verkman</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy</article-title>
          <source>J. Gen. Physiol.</source>
          <year>2004</year>
          <volume>124</volume>
          <fpage>125</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="pmid">15277574</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>[23]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>F.Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Loh</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Inhibitory effect of endothelin-1 on the isoproterenol-induced chloride current in human cardiac myocytes</article-title>
          <source>Eur. J. Pharmacol.</source>
          <year>2001</year>
          <volume>424</volume>
          <fpage>97</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">11476755</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>[24]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koster</surname>
              <given-names>O.F.</given-names>
            </name>
            <name>
              <surname>Szigeti</surname>
              <given-names>G.P.</given-names>
            </name>
            <name>
              <surname>Beuckelmann</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of a [Ca2+]i-dependent current in human atrial and ventricular cardiomyocytes in the absence of Na+ and K+</article-title>
          <source>Cardiovasc. Res.</source>
          <year>1999</year>
          <volume>41</volume>
          <fpage>175</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="pmid">10325965</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>(A) Representative anion-sensitive whole-cell currents (<italic>I</italic>, normalized to membrane capacitance) evoked by 500 ms depolarizing ramps from −90 to +70 mV from a holding potential of −50 mV (see inset) during superfusion with external solutions containing different anions (solutions C, B, E or D, respectively). (B) Representative Cl<sup>−</sup>, <mml:math id="M20" altimg="si1.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and I<sup>−</sup>-sensitive current (<italic>I</italic>) for the same cell calculated by subtracting the current recorded during depolarizing ramps in the presence of aspartate from those in the presence of Cl<sup>−</sup>, <mml:math id="M21" altimg="si2.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> or I<sup>−</sup>, respectively. (C) Mean normalized values of anion currents obtained at +60 mV (<mml:math id="M22" altimg="si3.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>, <italic>n</italic> = 7; Cl<sup>−</sup>, <italic>n</italic> = 7; I<sup>−</sup>, <italic>n</italic> = 6. *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.001 compared to <mml:math id="M23" altimg="si4.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>).</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>(A) Plot of the mean <italic>I</italic>–<italic>V</italic> relations of <mml:math id="M24" altimg="si5.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>-sensitive current (solution E, <italic>n</italic> = 19). (B) Plot of the mean <italic>I</italic>–<italic>V</italic> relations of <mml:math id="M25" altimg="si6.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>-sensitive current recorded in hyperosmolar solution (solution F, <italic>n</italic> = 8, <italic>p</italic> &gt; 0.05 vs. <mml:math id="M26" altimg="si7.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> of normal osmolarity (solution E), two-way ANOVA). (C) Effects of drugs on <mml:math id="M27" altimg="si8.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>-sensitive current at +60 mV, expressed as percentage of the control current value before the addition of the drug (<mml:math id="M28" altimg="si9.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>, <italic>n</italic> = 15, NPPB (50 μM), <italic>n</italic> = 5, Gly H-101 (30 μM), <italic>n</italic> = 8, Gly H-101 (10 μM), <italic>n</italic> = 4, DIDS (200 μM), <italic>n</italic> = 5 and TEF (10 μM), <italic>n</italic> = 8. *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.001 compared to <mml:math id="M29" altimg="si10.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>(A) Simulated human atrial action potentials with and without (Control) inclusion of <italic>I</italic><sub>ANION</sub> (with each of <mml:math id="M30" altimg="si11.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math> and Cl<sup>−</sup> as charge carrier). (B) Profile of <italic>I</italic><sub>ANION</sub> during each of the action potentials shown in panel A. (C) Profile of L-type Ca<sup>2+</sup> current (<italic>I</italic><sub>Ca,L</sub>) during each of the action potentials shown in panel A, in control and with <mml:math id="M31" altimg="si12.gif" overflow="scroll"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:none/><mml:none/><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math>-dependent and Cl<sup>−</sup>-dependent <italic>I</italic><sub>ANION</sub>.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <table-wrap position="float" id="tbl1">
      <label>Table 1</label>
      <caption>
        <p>Composition of solutions used in this study</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th>Chemical</th>
            <th colspan="9">Solution (concentration, mM)<hr/></th>
          </tr>
          <tr>
            <th/>
            <th>A<sup>1</sup></th>
            <th>B<sup>2</sup></th>
            <th>C<sup>2</sup></th>
            <th>D<sup>2</sup></th>
            <th>E<sup>2</sup></th>
            <th>F<sup>2</sup></th>
            <th>G<sup>3</sup></th>
            <th>H<sup>1</sup></th>
            <th>I<sup>2</sup></th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>NaCl</td>
            <td>145</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>137</td>
            <td>−</td>
          </tr>
          <tr>
            <td>KCl</td>
            <td>4</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>MgCl<sub>2</sub></td>
            <td>1</td>
            <td>2.5</td>
            <td>2.5</td>
            <td>2.5</td>
            <td>2.5</td>
            <td>2.5</td>
            <td>−</td>
            <td>−</td>
            <td>0.5</td>
          </tr>
          <tr>
            <td>CaCl<sub>2</sub></td>
            <td>2</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>Glucose</td>
            <td>10</td>
            <td>10</td>
            <td>10</td>
            <td>10</td>
            <td>10</td>
            <td>10</td>
            <td>140</td>
            <td>10</td>
            <td>−</td>
          </tr>
          <tr>
            <td>HEPES</td>
            <td>10</td>
            <td>5</td>
            <td>5</td>
            <td>5</td>
            <td>5</td>
            <td>5</td>
            <td>10</td>
            <td>5</td>
            <td>−</td>
          </tr>
          <tr>
            <td>NMDG-Cl</td>
            <td>−</td>
            <td>135</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>NMDG-Aspartate</td>
            <td>−</td>
            <td>−</td>
            <td>135</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>NMDG-I</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>135</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>NMDG-NO<sub>3</sub></td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>135</td>
            <td>135</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>TEACl</td>
            <td>−</td>
            <td>5</td>
            <td>5</td>
            <td>5</td>
            <td>5</td>
            <td>5</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>BaCl<sub>2</sub></td>
            <td>−</td>
            <td>2</td>
            <td>2</td>
            <td>2</td>
            <td>2</td>
            <td>2</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>CdCl<sub>2</sub></td>
            <td>−</td>
            <td>0.5</td>
            <td>0.5</td>
            <td>0.5</td>
            <td>0.5</td>
            <td>0.5</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>Sucrose</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>70</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>Cs glutamate</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>75</td>
          </tr>
          <tr>
            <td>CsCl</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>20</td>
          </tr>
          <tr>
            <td>CsEGTA</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>0.05</td>
          </tr>
          <tr>
            <td>MgATP (tris-salt)</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>10</td>
          </tr>
          <tr>
            <td>Tris-phosphocreatine</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>5</td>
          </tr>
          <tr>
            <td>Tris-GTP</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>0.1</td>
          </tr>
          <tr>
            <td>Pyruvic acid</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>5</td>
          </tr>
          <tr>
            <td><sup>4</sup>Pipes</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>30</td>
          </tr>
          <tr>
            <td>Adenosine</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>5</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>EGTA</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>0.2</td>
            <td>−</td>
          </tr>
          <tr>
            <td>KH<sub>2</sub>PO<sub>4</sub></td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>50</td>
            <td>5</td>
            <td>−</td>
          </tr>
          <tr>
            <td>Mannitol</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>100</td>
            <td>−</td>
            <td>−</td>
          </tr>
          <tr>
            <td>MgSO<sub>4</sub></td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>−</td>
            <td>8</td>
            <td>1</td>
            <td>−</td>
          </tr>
          <tr>
            <td>Cl<sup>−</sup> concentration</td>
            <td>155</td>
            <td>150</td>
            <td>15</td>
            <td>15</td>
            <td>15</td>
            <td>15</td>
            <td>0</td>
            <td>137</td>
            <td>21</td>
          </tr>
          <tr>
            <td>Osmolarity (mOsm)</td>
            <td>308 ± 2.5</td>
            <td>305 ± 1.2</td>
            <td>306 ± 0.3</td>
            <td>310 ± 3</td>
            <td>305 ± 0.2</td>
            <td>365 ± 1.5</td>
            <td>383 ± 0.3</td>
            <td>282 ± 0.6</td>
            <td>308 ± 1.2</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Osmolarities for each solution are measured values (see Methods).</p>
          <p><italic>Note.</italic> pH 7.4 with <sup>1</sup>NaOH, <sup>2</sup>CsOH, <sup>3</sup>KOH; <sup>4</sup>pH 7.1 with CsCO<sub>3</sub>. Minus sign indicates absence.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-wrap>
</article>